retatrutide and heart Why Does Increase Rate? Dramatic Weight Loss, Cardiometabolic Improvement

First cardiovascular safety trial of a DPP-4 inhibitor in patients with T2DM and high cardiovascular risk, showing that saxagliptin does not augment MACE but increases hospitalization for heart failure

Stop Dieting

The new patent applications build on NorthStrive's previously announced intellectual property strategy for EL-22 and EL-32 and represent a strategic expansion from animal health and agricultural applications into potential human-use applications

These foods introduce beneficial bacteria into your gut, enhancing nutrient absorption and potentially increasing GLP-1 levels

Tirzepatide's dual agonism of GLP-1 and GIP receptors suggests a multifaceted approach to energy balance

Yang L, Chen L, Li D, Xu H, Chen J, Min X, He M, Wu T, Zhong J, Yang H